Compounds > n-succinimidyl 3-(trimethylstannyl)benzoate
Page last updated: 2024-09-03

n-succinimidyl 3-(trimethylstannyl)benzoate and Glioma

n-succinimidyl 3-(trimethylstannyl)benzoate has been researched along with Glioma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Choi, J; Murphy, S; Pozzi, OR; Vaidyanathan, G; Zalutsky, MR; Zhao, XG1

Other Studies

1 other study(ies) available for n-succinimidyl 3-(trimethylstannyl)benzoate and Glioma

ArticleYear
Labeling Monoclonal Antibody with α-emitting
    Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:7

    Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Astatine; Benzoates; Brain Neoplasms; Cell Line, Tumor; Glioma; Humans; Isotope Labeling; Mice; Radioimmunotherapy; Tissue Distribution; Trimethyltin Compounds; Xenograft Model Antitumor Assays

2020